One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

Kenvue’s stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark’s stock ...

Huggies’ maker Kimberly-Clark announced Monday it’s buying Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a consumer product conglomerate.

Irving-based Kimberly-Clark announced a blockbuster deal Monday morning to acquire consumer health care company Kenvue for ...

Kimberly-Clark said Monday it would acquire Kenvue for more than $40 billion in cash and stock, creating a consumer ...

Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, ...

Shareholders of Kimberly-Clark will own about 54% of the combined company. Two years ago, Johnson & Johnson spun off its ...

The announcement comes weeks after President Trump made claims linking Tylenol to autism in pregnant women's unborn babies, ...

Summit, NJ-based Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year.

Kimberly-Clark is buying Tylenol maker Kenvue in a $48.7 billion cash-and-stock deal, creating a massive consumer health ...

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...